A Real-World Assessment Of Risk For Severe Stroke And Post-Stroke Mortality In Non-Valvular Atrial Fibrillation Patients Treated With Rivaroxaban And Warfarin

Mark Alberts,Yen-Wen Chen,Jennifer Lin,Zhijie Ding,Deepti Bisht,Emily Kogan,Kathryn Twyman,Dejan Milentijevic

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2019）

引用 0|浏览6

暂无评分

摘要

Effectiveness of rivaroxaban vs warfarin in patients with non-valvular atrial fibrillation (NVAF) is not well-understood over long follow up time in real-world settings. This study compared risk for stroke by severity and post-stroke mortality between rivaroxaban and warfarin.This retrospective

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要